Effects of resistin expression on glucose metabolism and hepatic insulin resistance

Fang-Ping Li; Juan He; Zhi-Zhen Li; Zhao-Fan Luo; Li Yan; Yan Li
April 2009
Endocrine (1355008X);Apr2009, Vol. 35 Issue 2, p243
Academic Journal
Abstract  In order to observe the effect of increased serum resistin on glucose metabolism, insulin sensitivity, and hepatic insulin resistance (IR), mice were intravenously injected with recombinant adenovirus carrying the resistin gene (Adv-resistin-EGFP). Changes in hepatic glucose metabolism were observed using the Periodic Acid-Schiff method. Hepatic AMP-activated protein kinase (AMPK) activation was assessed by Western blot analysis, and glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression was determined using real-time RT-PCR. Although no effect on fasting blood glucose was detected, increased fasting insulin levels, decreased glucose tolerance and insulin sensitivity, and reduced hepatic glycogen levels and AMPK activation were seen in the Adv-resistin-EGFP mice. Finally, elevated G6Pase and PEPCK mRNA expression levels were detected upon overexpression of resistin. Resistin may inhibit hepatic AMPK activity, which results in elevated expression of gluconeogenic enzymes thereby affecting glucose metabolism and leading to decreased glycogen storage that contributes to the development of hepatic IR.


Related Articles

  • Regulation of liver glucokinase activity in rats with fructose-induced insulin resistance and impaired glucose and lipid metabolism. Francini, Flavio; Castro, Mar�a C.; Gagliardino, Juan J.; Massa, Mar�a L. // Canadian Journal of Physiology & Pharmacology;Sep2009, Vol. 87 Issue 9, p702 

    We evaluated the relative role of different regulatory mechanisms, particularly 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFK2/FBPase-2), in liver glucokinase (GK) activity in intact animals with fructose-induced insulin resistance and impaired glucose and lipid metabolism. We...

  • Involvement of KLF11 in Hepatic Glucose Metabolism in Mice via Suppressing of PEPCK-C Expression. Zhang, Huabing; Chen, Qi; Jiao, Tao; Cui, Anfang; Sun, Xiujing; Fang, Weijun; Xie, Liwei; Liu, Yang; Fang, Fude; Chang, Yongsheng // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Background: Abnormal hepatic gluconeogenesis is related to hyperglycemia in mammals with insulin resistance. Despite the strong evidences linking Krüppel-like factor 11 (KLF11) gene mutations to development of Type 2 diabetes, the precise physiological functions of KLF11 in vivo remain...

  • Effect of Prolonged Intermittent Hypoxia and Exercise Training on Glucose Tolerance and Muscle GLUT4 Protein Expression in Rats. Li-Ling Chiu; Shih-Wei Chou; Yu-Min Cho; Hsin-Yi Ho; Ivy, John L.; Hunt, Desmond; Wang, Paulus S.; Chia-Hua Kuo // Journal of Biomedical Science;Nov/Dec2004, Vol. 11 Issue 6, p838 

    We compared the chronic effect of intermittent hypoxia and endurance training on the glucose tolerance and GLUT4 protein expression in rat skeletal muscle. Thirty-two Sprague-Dawley rats were matched for weight and assigned to one of the following four groups: control, endurance training,...

  • ChREBP-β isoform: A novel target for diabetes treatment.  // Diabetes Digest;2012, Vol. 11 Issue 3, p149 

    The article discusses a study to evaluate a novel carbohydrate-responsive element-binding protein (ChREBP) isoform in adipose tissue regulates systemic glucose metabolism, which found that in obese people, ChREBPß expression correlates with insulin sensitivity.

  • The Relationship between Selenoprotein P and Glucose Metabolism in Experimental Studies. Jinyuan Mao; Weiping Teng // Nutrients;Jun2013, Vol. 5 Issue 6, p1937 

    Selenium is an essential trace element in the diet of mammals which is important for many physiological functions. However, a number of epidemiological studies have suggested that high selenium status is a possible risk factor for the development of type 2 diabetes, although they cannot...

  • Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome. De Ita, J. Rodríguez; Castilla-Cortázar, I.; Aguirre, G. A.; Sánchez-Yago, C.; Santos-Ruiz, M. Olleros; Guerra-Menéndez, L.; Martín-Estal, I.; García-Magariño, M.; Lara-Díaz, V. J.; Puche, J. E.; Muñoz, U. // Journal of Translational Medicine;10/14/2015, Vol. 13, p1 

    Background: Insulin growth factor 1 (IGF-1) has multiple effects on metabolism. Much evidence suggests that the deficiency of this hormone increases insulin resistance, impairs lipid metabolism, augments oxidative damage and deregulates the neuro-hormonal axis. An inverse...

  • Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging. Zemva, J.; Udelhoven, M.; Moll, L.; Freude, S.; Stöhr, O.; Brönneke, H.; Drake, R.; Krone, W.; Schubert, M. // Age;Oct2013, Vol. 35 Issue 5, p1881 

    The insulin receptor substrates (IRS) are adapter proteins mediating insulin's and IGF1's intracellular effects. Recent data suggest that IRS2 in the central nervous system (CNS) is involved in regulating fuel metabolism as well as memory formation. The present study aims to specifically define...

  • Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice. Pang, Jingbo; Rhodes, Davina H.; Pini, Maria; Akasheh, Rand T.; Castellanos, Karla J.; Cabay, Robert J.; Cooper, Dianne; Perretti, Mauro; Fantuzzi, Giamila // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Obesity and type 2 diabetes are associated with increased production of Galectin-3 (Gal-3), a protein that modulates inflammation and clearance of glucose adducts. We used Lean and Diet-induced Obese (DIO) WT and Gal-3 KO mice to investigate the role of Gal-3 in modulation of adiposity, glucose...

  • Viewpoints on the Way to a Consensus Session. Perseghin, Gianluca // Diabetes Care;Nov2009 Supplement, Vol. 32, pS164 

    The article discusses the role of the liver in the onset of insulin resistance and insulin resistance syndrome. It tackles nonalcoholic fatty liver disease (NAFLD) as the hepatic counterpart of the metabolic syndrome. The role played by high intrahepatic fat (IHF) content in liver damage and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics